Executive Management

Chief Executive Officer: Daryl H. Faulds, Ph.D.

Dr. Faulds has over 20 years of experience in molecular biology, immunology and pharmaceutical development. Most recently he led the Berlex Biosciences (the US subsidiary of Schering AG) project team for Influenza A therapeutics. He has led projects in respiratory disease (Mycoplasma pneumonia), autoimmune disease (Multiple sclerosis, MS) and basic research. In addition he has served on international project teams for HPV vaccines and bioinformatics. This background has given him extensive experience in pre-clinical project management and management of the transition from research to the clinic. Dr. Faulds earned his BA in biology at Revelle College, University of California, San Diego and his Ph.D. in Molecular Biology at the Institute of Molecular Biology, University of Oregon. Following his doctoral studies, Dr. Faulds was a National Institutes of Health (NIH) postdoctoral fellow in the Department of Microbiology and Immunology at the University of California, Berkeley.

President: William J. Guilford, Ph.D.

Dr. Guilford has over 20 years of experience in biotechnology and pharmaceutical research and development. Dr. Guilford leads the medicinal chemistry effort and manages research collaborations. In previous positions at Berlex Biosciences (the US subsidiary of Schering AG), ImmuLogic and Sogetal, Dr. Guilford gained extensive experience in medicinal chemistry in both the cardiovascular and immunology therapeutic areas. Three of his four drug candidates have entered into clinical trial. Dr. Guilford is an author on over 30 peer-reviewed journal articles and is an inventor on over 30 issued patents and patent applications. Dr. Guilford earned his BS in chemistry at University of California, Berkeley and his Ph.D. in Chemistry at University of Illinois at Urbana / Champaign. Following his doctoral studies, Dr. Guilford was a National Institutes of Health (NIH) postdoctoral fellow at the Swiss Federal Institute of Technology in Zurich (ETH-Z) and a postdoctoral fellow at Harvard University.